Bone Research · 2014 · 25 citations · 36 references
Life SciencesImmunologyOral BiologyBone MetabolismInnate ImmunitySignal TransductionCytokine BiologyHost Immune ResponseInflammatory SignalingOsteoblast BiologyOsteoblast FunctionOsteogenesisAcute Inflammatory ResponseCollagen GelsInflammation In Bone RepairInflammatory Mediator ResponseOsteogenic DifferentiationOsteogenic MarkersPhosphatase Inhibition
Toll-like receptor (TLR)-mediated inflammatory response could negatively affect bone metabolism. In this study, we determined how osteogenesis is regulated during inflammatory responses that are downstream of TLR signaling. Human primary osteoblasts were cultured in collagen gels. Pam3CSK4 (P3C) and Escherichia coli lipopolysaccharide (EcLPS) were used as TLR2 and TLR4 ligand respectively. Porphyromonas gingivalis LPS having TLR2 activity with either TLR4 agonism (Pg1690) or TLR4 antagonism (Pg1449) and mutant E. coli LPS (LPxE/LPxF/WSK) were used. IL-1β, SH2-containing inositol phosphatase-1 (SHIP1) that has regulatory roles in osteogenesis, alkaline phosphatase and mineralization were analyzed. 3α-Aminocholestane (3AC) was used to inhibit SHIP1. Our results suggest that osteoblasts stimulated by P3C, poorly induced IL-1β but strongly upregulated SHIP1 and enhanced osteogenic mediators. On the contrary, EcLPS significantly induced IL-1β and osteogenic mediators were not induced. While Pg1690 downmodulated osteogenic mediators, Pg1449 enhanced osteogenic responses, suggesting that TLR4 signaling annuls osteogenesis even with TLR2 activity. Interestingly, mutant E. coli LPS that induces weak inflammation upregulated osteogenesis, but SHIP1 was not induced. Moreover, inhibiting SHIP1 significantly upregulated TLR2-mediated inflammatory response and downmodulated osteogenesis. In conclusion, these results suggest that induction of weak inflammatory response through TLR2 (with SHIP1 activity) and mutant TLR4 ligands could enhance osteogenesis. US researchers have uncovered how the immune system interacts with the skeletal system to influence bone formation and turnover. Led by Manoj Muthukuru from West Virginia University in Morgantown, the researchers looked at how bone formation is regulated during inflammation. Chronic inflammatory conditions like arthritis can affect the precise interplay between cells responsible for bone formation (osteoblasts) and bone resorption (osteoclasts). Osteoblasts express proteins called Toll-like receptors (TLRs), which interact with the immune system to recognise microbial structures, but little is known about how this interaction affects bone formation. Analysing human osteoblasts, the researchers discovered that activation of TLR-2 contributed to an inflammatory response that enhanced bone-forming activities (osteogenesis). The authors conclude that targeting these inflammatory responses could be a novel therapeutic approach to boosting bone production in people with inflammatory bone disease.
36
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Verónica Mata‐Haro, Caglar Cekic, Michael Martin et al. · Science · 2007 · 891 citations
Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-α*
Linda Gilbert, Xiaofei He, Paul Farmer et al. · Endocrinology · 2000 · 550 citations · Full text
Gil Melmed, Lisa Thomas, Nahee Lee et al. · The Journal of Immunology · 2003 · 427 citations · Full text
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
R B Sartor · PubMed · 1997 · 396 citations
Life Sciences, Immunology, Pathology +17
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Laura M. Sly, Michael J. Rauh, Janet Kalesnikoff et al. · Immunity · 2004 · 304 citations · Full text